A61P 31/14
For rna viruses
Official title: for RNA viruses
A61P31/14 (For rna viruses) appears on 19,145 US grants and 31,430 published applications in this corpus.
Search patents in A61P- Granted patents
- 19,145
- Published applications
- 31,430
- Assignees
- 8,091
- Inventors
- 47,993
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 6 | 0 |
| 1990 | 14 | 0 |
| 1991 | 19 | 0 |
| 1992 | 22 | 0 |
| 1993 | 30 | 0 |
| 1994 | 24 | 0 |
| 1995 | 42 | 0 |
| 1996 | 90 | 0 |
| 1997 | 138 | 0 |
| 1998 | 189 | 0 |
| 1999 | 232 | 0 |
| 2000 | 285 | 0 |
| 2001 | 341 | 86 |
| 2002 | 364 | 494 |
| 2003 | 416 | 894 |
| 2004 | 319 | 1115 |
| 2005 | 318 | 1132 |
| 2006 | 449 | 1096 |
| 2007 | 490 | 1244 |
| 2008 | 526 | 1282 |
| 2009 | 699 | 1517 |
| 2010 | 866 | 1900 |
| 2011 | 866 | 1825 |
| 2012 | 1060 | 1737 |
| 2013 | 1084 | 1289 |
| 2014 | 1214 | 1377 |
| 2015 | 1001 | 1179 |
| 2016 | 935 | 1147 |
| 2017 | 955 | 1122 |
| 2018 | 853 | 1115 |
| 2019 | 826 | 1146 |
| 2020 | 767 | 1039 |
| 2021 | 739 | 1191 |
| 2022 | 670 | 1240 |
| 2023 | 613 | 1960 |
| 2024 | 634 | 1562 |
| 2025 | 574 | 1126 |
| 2026 | 451 | 615 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Application of TFF2 protein and IFN-κ protein combination in treatment of a novel coronavirus infection6 Oct 2026US 12,751,996 B2Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Immunostimulatory adjuvants6 Oct 2026US 12,752,000 B2Orionis Biosciences BV
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Polypeptides, compositions, and their use to treat or limit development of an infection6 Oct 2026US 12,752,002 B2University of Washington
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Antiviral infusion composition8 Oct 2026US 2026/0306518 A1
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306563 A1Societe des Produits Nestle S. A.
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306564 A1Societe des Produits Nestle S. A.
- Production method8 Oct 2026US 2026/0306577 A1AG IP Company Pty Ltd
Most cited
By later US patents
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Process for preparing diaminophenothiazinium compounds687US 8,765,942 B2Provence Technologies · 2014
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Human monoclonal antibodies to programmed death ligand 1 (PD-L1)628US 7,943,743 B2Medarex, Inc. · 2011